Angiotensin II (AGT-2) induces follicular prostaglandin release in a number of species and ovulation in rabbits. Conversely, AGT-2 antagonists block ovulation in cattle. To determine the mechanism of action of AGT-2, we used a bovine granulosa cell model in which luteinizing hormone (LH) increased the expression of genes essential for ovulation in a time-and dose-dependent manner. The addition of AGT-2 to LHstimulated cells significantly increased abundance of prostaglandin-endoperoxide synthase 2 (PTGS2) mRNA and protein, whereas AGT-2 alone had no effect. Upstream of PTGS2, AGT-2 increased abundance of mRNA encoding the epidermal growth factor-like ligands amphiregulin (AREG) and epiregulin (EREG) at 6 h posttreatment and abundance of a disintegrin and metalloprotease 17 (ADAM17), a sheddase, within 3 h of treatment. Inhibiting sheddase activity abolished the stimulatory effect of AGT-2 on AREG, EREG, and PTGS2 mRNA. The addition of selective AGT-2 antagonists to cells stimulated with LH plus AGT-2 demonstrated that AGT-2 did not act through the type 1 receptor and did not increase mitogen-activated protein kinase 3/1 phosphorylation. Combined with previous data from studies in vitro, we conclude that AGT-2 is an essential cofactor for LH in the early increase of ADAM expression/activity that induces the cascade of events leading to ovulation.
INTRODUCTION
The preovulatory surge of luteinizing hormone (LH) initiates a cascade of events in preovulatory follicles that culminates in rupture of the follicle wall and release of the oocyte-cumulus complex. A key element of this cascade is the production of prostaglandins by granulosa cells [1] . Prostaglandins are produced by a LH-inducible enzyme, prostaglandin-endoperoxide synthase 2 (PTGS2) [2] . The critical roles of PTGS2 and prostaglandins have been demonstrated in a number of models-for example, the inhibition of ovulation in rodents, pigs, and ruminants by the broad-spectrum prostaglandin inhibitor indomethacin [3] [4] [5] [6] . Further, intrafollicular injection of a PTGS2-selective inhibitor in cattle inhibited ovulation [7] , and PTGS2-null mice failed to ovulate [8] . Prostaglandins act, at least in part, by stimulating the expression of proteases, including plasminogen activators, in the follicle wall [9] [10] [11] .
Over the last few years, further details of the LH-induced cascade leading to PTGS2 expression have been elucidated that involve the epidermal growth factor (EGF)-like factors amphiregulin (AREG) and epiregulin (EREG). These factors were identified as genes rapidly induced by LH in granulosa cells and by EGF in cumulus cells [12] [13] [14] . According to current hypotheses, LH induces the release of AREG/EREG from the surface of mural granulosa cells, which then act in a paracrine manner to stimulate the EGF receptor of cumulus cells [15, 16] . EGF receptor activation results in AREG/EREG expression in the cumulus and increased PTGS2 expression.
Ovulation can be induced or inhibited by factors other than LH. One example is angiotensin II (AGT-2), which induced ovulation in perfused rabbit ovaries [17, 18] . Conversely, AGT-2 antagonists inhibit ovulation in rodents, rabbits, and cattle [19] [20] [21] . Follicular AGT-2 is produced by conversion of circulating angiotensin I by angiotensin-converting enzyme (ACE) located in endothelial cells of the theca interna [22, 23] ; no clear evidence shows ACE activity in granulosa cells [24] . Elegant microdialysis studies demonstrated that follicular AGT-2 content increased within 24 h of an ovulatory LH surge [25] . AGT-2 likely induces ovulation through increased follicular prostaglandin secretion [17, 19, 26] , although how this is achieved is unclear for two reasons. First, although AGT-2 has been shown to upregulate PTGS2 mRNA levels in the vascular system [27] [28] [29] , kidney [30] , and intestinal epithelium [31] , the target gene of AGT-2 in the ovary is unknown. Second, AGT-2 stimulated PTGS2 through the type 1 AGT-2 receptor (AGTR1) and mitogen-activated protein kinases (MAPKs) in the nonreproductive tissues mentioned above, whereas the effect of AGT-2 on ovulation appears to be mediated through the type 2 AGT-2 receptor (AGTR2) [17, 19, 21] . The objectives of the present study were to elaborate a bovine granulosa culture system in which the expression of genes in the ovulatory cascade are responsive to LH and then use this system to determine how AGT-2 impacts ovulation in ruminants.
MATERIALS AND METHODS

Cell Culture
To minimize potential confounding effects of renin-angiotensinogen molecules in serum [32] , we employed a granulosa cell culture system in which treatments were applied under defined conditions. Bovine ovaries were collected from adult cows, irrespective of stage of the estrous cycle, at a local abattoir and were transported to the laboratory in PBS at 358C containing penicillin (100 IU/ml), streptomycin (100 lg/ml), and fungizone (1 lg/ml). Five to eight ovaries, depending on the experiment, that each contained a single large follicle (diameter, .10 mm) were selected for each replicate. Cells were collected from the large follicle by aspiration, pooled, and washed twice by centrifugation at 219 3 g for 20 min each. Cell viability was estimated with 0.4% Trypan blue stain. Cells were seeded into 24-well tissue culture plates (Sarstedt) at a density of 1 3 10 6 viable cells per well in 1 ml of Dulbecco modified Eagle medium-Ham F12 (DMEM-F12) supplemented with sodium bicarbonate (10 mM), sodium selenite (4 ng/ml), bovine serum albumin (BSA; 0.1%; Sigma-Aldrich Canada), penicillin (100 IU/ml), streptomycin (100 lg/ ml), transferrin (2.5 lg/ml), nonessential amino acid mix (1.1 mM), androstenedione (10 À7 M), follicle-stimulating hormone (FSH; 1 ng/ml), insulin (10 ng/ml), and 2% fetal calf serum (Hyclone). Cultures were maintained at 378C in 5% CO 2 for 24 h. Medium was then replaced with serum-free DMEM-F12 without supplementation for 18 h. A final change of serum-free DMEM-F12 was then performed, at which point treatments were added. Preliminary experiments indicated that the inclusion of serum and FSH in the first 24 h of culture was important for consistent increases in PTGS2 mRNA or progesterone secretion in response to LH.
Cells were stimulated with bovine LH (AFP11743B; NIDDK), AGT-2 (A6402; Sigma-Aldrich), or LH with AGT-2 at the doses and time periods described in Results, after which medium and/or cells were recovered for analysis. In some experiments, cells were treated 1 h before AGT-2/LH treatment with the AGTR1 antagonist Losartan (10 lM; Merck & Co., Inc.), the AGTR2 antagonist PD123,319 (10 lM, Sigma-Aldrich), or the metallopeptidase inhibitor Galardin (10 lM, Sigma-Aldrich).
Nucleic Acid Extraction and RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's instructions and quantified by absorbance at 260 nm. Total RNA (1 lg) was first treated with 1 U of DNase (Promega) at 378C for 30 min to digest any contaminating DNA, followed by adding 1 ll of ethylenediaminetetra-acetic acid stop buffer at 658C for 10 min. The RNA was reverse transcribed in the presence of 1 mM oligo(dT) primer and 4 U of Omniscript RTase (Omniscript RT Kit; Qiagen), 0.25 mM dideoxy-nucleotide triphosphate (dNTP) mix, and 19.33 U of RNase Inhibitor (GE Healthcare Canada) in a volume of 20 ll at 428C for 2 h. The reaction was terminated by incubation at 938C for 5 min.
Bovine-specific primer sequences were taken from the literature for urokinase plasminogen activator (PLAU) [33] and steroidogenic acute regulatory protein (STAR) [34] , whereas those for PTGS2, AREG, EREG, a disintegrin and metalloprotease 17 (ADAM17), and AGTR2 were designed with Primer Express (Applied Biosystems) and are given in Table 1 . Real-time PCR was performed in an ABI Prism 7300 instrument (Applied Biosystems) with Power SYBR Green PCR Master Mix (Applied Biosystems). Common thermal cycling parameters (3 min at 958C, followed by 40 cycles of 15 sec at 958C, 30 sec at 608C, and 30 sec at 728C) were used to amplify each transcript. Amplicon identity was established by sequencing products of new primers and by melting-curve analyses conducted after every reaction. Samples were run in duplicate and were expressed relative to histone H2AFZ [35] as housekeeping gene. Data were normalized to a calibrator sample using the Pfaffl DDCt method with correction for amplification efficiency [36] .
Immunofluorescence
Abundance of PTGS2 protein was measured in bovine granulosa cells in vitro by immunofluorescence. Cells were cultured as described above with LH (100 ng/ml), AGT-2 (10 À5 M), or both for 12 h, at which point the cells were fixed in 4% paraformaldehyde for 20 min, washed five times for 5 min each in PBS, and blocked in 5% BSA for 1 h, after which 1:200 PTGS2 antibody (catalog no. PG26; Oxford Biomedical Research) was applied for 18 h at 48C. After the primary antibody, the cells were washed in PBS and then incubated with Cy3-conjugated second antibody (Jackson ImmunoResearch) and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI). Negative controls were performed in the absence of primary antibody. Digital images were captured, and mean fluorescence intensity in each field was quantified with ImageJ (National Institutes of Health [NIH] ). The number of cells in the field was quantified by counting DAPI-stained nuclei, and the staining was expressed as units/cell.
Western Blot Analysis
Activation of MAPK3/1 was assayed by Western blot analysis. Cells were cultured as described above and were challenged with LH (100 ng/ml), AGT-2 (10 À5 M), or both. Some wells were harvested after 15 min for protein extraction and Western blot analysis, and some wells were harvested at 6 h for RNA extraction (as described above) to measure EREG mRNA abundance. For protein extraction, cells were washed with cold PBS and lysed in 100 ll/well of   FIG. 2 . Effect of dose of LH on abundance of mRNA encoding genes involved in the ovulatory cascade and AGTR2 in granulosa cells. Cells were cultured as described in the legend for Figure 1 and were treated for 6 h with the indicated doses of LH. Messenger RNA abundance was measured by real-time PCR. Data represent the mean 6 SEM for three independent replicate cultures. Bars with the same letters are not significantly different (P . 0.05).
FIG. 3. Effect of AGT-2 and LH on
progesterone secretion and the abundance of mRNA encoding genes involved in luteinization and the ovulatory cascade in granulosa cells. Cells were cultured as described in Figure 1 , and LH (100 ng/ml) or LH plus AGT-2 (10 À5 M) were added for the times shown. Messenger RNA abundance was measured by real-time PCR. Data represent the mean 6 SEM for three independent replicate cultures. An asterisk (*) denotes a significant effect of AGT-2 (P , 0.05) at each time point.
cold RIPA buffer (25 mM Tris-HCL [pH 7.6], 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, and protease inhibitor cocktail). The homogenate was centrifuged at 6000 3 g for 5 min at 48C. The resulting supernatant was retained and stored at À208C. Protein concentrations were determined by BCA protein assay (Pierce).
Samples were resolved on 10% SDS-PAGE (15 lg of total protein per lane) and electrophoretically transferred onto nitrocellulose membrane in a Bio-Rad Wet Blot Transfer Cell apparatus (transfer buffer: 39 mM glycine, 48 mM Trisbase, 1% SDS, and 20% methanol; pH 8.3). After transfer, the membranes were blocked in 5% nonfat dry milk in TTBS (10 mM Tris-HCL, 150 mM NaCl, and 0.1% Tween-20; pH 7.5) for 1 h. Membranes were incubated overnight with the primary antibody (anti-MAPK, #9102, 1:2000; anti-phospho-MAPK, #9101, 1:1000; Cell Signaling Technology) diluted in 5% BSA in TTBS at 48C. After washing three times with TTBS, membranes were incubated for 2 h at room temperature with 1:10 000 anti-rabbit horseradish peroxidase-conjugated immunoglobulin G (GE Healthcare Canada) diluted in 5% nonfat dry milk in TTBS. After five washes in TTBS, protein bands were revealed by chemiluminescence (Immobilon; Millipore) and autoradiography. Semiquantitative analysis was performed with NIH Image J software.
Steroid Assay
Progesterone was measured in duplicate as described previously [37] , with mean intra-and interassay coefficients of variation of 7.2% and 18%, respectively. The sensitivity of the assay was 4 pg/tube, equivalent to 20 ng/lg protein. Steroid concentrations in culture medium were corrected for cell number by expressing per unit mass of total protein.
Statistical Analysis
Data that did not follow a normal distribution (Shapiro-Wilk test) were transformed to logarithms. Homogeneity of variance was tested with O'Brien and Brown-Forsythe tests. Analysis of data was performed with JMP software (SAS Institute), with treatment or follicle group as main effect and culture replicate (where appropriate) as a random variable in the F-test. Differences between means were tested with the Tukey-Kramer honestly significant difference test or compared to treatment control with the Dunnett test. Data are presented as the mean 6 SEM.
RESULTS
To characterize the responsiveness of the cells to LH under the present culture conditions, time-course and dose-response experiments were performed. The time-course experiment started at the time of LH or vehicle challenge 18 h after the change to serum-free medium and revealed that under basal (no LH) conditions, EREG, AREG, and PLAU mRNA levels were stable, whereas PTGS2 levels decreased over time (P , 0.01) (Fig. 1A) . In the presence of LH (400 ng/ml), EREG, AREG, and PLAU mRNA levels increased with time (P , 0.05) (Fig.  1A) . Differences between control and LH treatment were observed for EREG within 1 h, for AREG and PTGS2 at 6 h, and for PLAU mRNA at 12 h (Fig. 1B) . The effect of dose of LH on AREG, EREG, and PTGS2 mRNA levels was then tested at the 6-h time point. LH had a significant dosedependent stimulatory effect on PTGS2, AREG, and EREG mRNA abundance (Fig. 2) .
We then investigated the action of AGT-2 in the ovulatory process. To do so, we selected a dose of LH (100 ng) that resulted in increases of PTGS2, AREG, and EREG mRNA levels that did not reach significance and that had no effect on AGTR2 mRNA levels (Fig. 2) . The addition of AGT-2 to the low dose of LH increased PLAU mRNA abundance at 6 h but did not alter the luteinization markers, progesterone secretion, and STAR mRNA levels (Fig. 3) . We then measured PTGS2, AREG, and EREG mRNA. Compared to the low dose of LH alone, AGT-2 significantly increased PTGS2, AREG, and EREG mRNA at 6 h and also increased PTGS2 and AREG mRNA at the later time point of 24 h (Fig. 3) .
The effect of AGT-2 on PTGS2 protein was determined by immunofluorescence 12 h after LH challenge (Fig. 4) . Neither LH nor AGT-2 alone stimulated PTGS2 protein levels above   FIG. 4 . Effect of LH and AGT-2 on PTGS2 protein as assessed by immunofluorescence in granulosa cells in vitro. Cells were cultured as described in Figure 1 and fixed after 12 h of treatment with LH (100 ng/ml), AGT-2 (10 À5 M), or both. Controls (Ctl) were treated with vehicle only. A) Representative photomicrographs showing PTGS2 immunofluorescence as determined by Cy3 (red) and cell density as determined by DAPI staining (blue). A negative control was included in each culture by omitting primary antibody (Antibody control). B) Quantification of PTGS2 protein corrected for cell number. Data represent the mean 6 SEM for three independent replicate cultures. Bars with the same letters are not significantly different (P . 0.05).
those of untreated controls, but in combination, they significantly increased PTGS2 protein levels (P , 0.001).
It has been demonstrated that activation of the ovulatory cascade is dependent on ligand shedding from the cell surface; therefore, we determined the importance of sheddase activity for AGT-2 action. Cells were pretreated with the broadspectrum sheddase inhibitor Galardin, and the effect on AGT-2 action was assessed after 6 h. AGT-2 plus LH increased PTGS2, AREG, and EREG mRNA levels above those observed with LH or AGT-2 alone, as before (Fig. 5 ), whereas pretreatment with Galardin effectively blocked the effect of AGT-2 plus LH on AREG, EREG, and PTGS2 mRNA abundance (Fig. 5) . A higher dose of AGT-2 alone (10 À3 M) had no effect on AREG, EREG, and PTGS2 mRNA levels.
One major sheddase in granulosa cells is ADAM17; therefore, we performed experiments with samples collected at 1, 3, and 6 h after treatment. AGT-2 plus LH induced a 6-fold increase in ADAM17 mRNA levels compared with LH alone at 1 and 3 h, whereas by 6 h, ADAM17 mRNA levels had returned to baseline (Fig. 6 ).
To explore potential mechanisms for the combined actions of LH and AGT-2, we determined if AGT-2 was acting through the AGTR1-MAPK pathway or through AGTR2. Pretreatment of cells for 1 h with the AGTR2-selective inhibitor PD123,319 effectively inhibited the stimulatory effect of AGT-2 at 6 h, whereas the selective AGTR1 inhibitor Losartan had no effect (Fig. 7A) . In a second experiment, proteins were recovered 15 min after treatment and RNA 6 h after treatment to measure MAPK1/3 phosphorylation and EREG mRNA levels in the same cell pools. AGT-2 alone did not alter EREG mRNA levels, but significantly enhanced LH-stimulated EREG mRNA abundance (Fig. 7B) , whereas no effect on MAPK3/1 phosphorylation was observed.
DISCUSSION
The present study provides novel insight regarding the role of AGT-2 in the ovulatory process in a model mammal. We have demonstrated that AGT-2 is ineffective alone but amplifies or sensitizes granulosa cell responsiveness to LH. AGT-2 increased LH-dependent PTGS2 mRNA and protein levels, as would be expected from the literature showing that AGT-2 increases prostaglandin secretion, but we also show that this is a consequence of upstream EGF-like ligand activity rather than a direct effect on PTGS2. Furthermore, we provide evidence that a primary target of AGT-2 action is EGF-ligand sheddase activity: AGT-2 stimulated a short-term increase in ADAM17 mRNA abundance, and addition of a sheddase inhibitor completely blocked the effect of AGT-2.
To study the role of AGT-2 in vitro, we employed a culture system that uses granulosa cells of large follicles obtained at an abattoir. In this system, LH increased PTGS2 and PLAU mRNA levels above those of time-matched controls at 6 to 12 h after challenge, which is consistent with the time course of human chorionic gonadotropin (hCG)/gonadotropin-releasing hormone (GnRH)-inducible increases in PTGS2 and PLAU mRNA abundance in cattle in vivo [38] [39] [40] [41] , although this is slightly earlier than in granulosa cells collected from preovulatory follicles and challenged with LH in vitro [42] . One caveat to the use of this culture system is that basal PTGS2 mRNA levels declined during the test period, which likely FIG. 5. EGF-like ligand shedding mediates the effect of AGT-2 on AREG, EREG, and PTGS2 mRNA abundance. Bovine granulosa cells were cultured as described in Figure 1 , and LH (100 ng/ml) or LH plus AGT-2 (10 À5 M) were added for 6 h. Pretreatment of cells for 1 h with the metalloprotease inhibitor Galardin effectively blocked the effect of AGT-2. Messenger RNA abundance was measured by real-time PCR. A high dose of AGT-2 (10 À3 M) without LH failed to stimulate these target genes. Data represent the mean 6 SEM for three independent replicate cultures. An asterisk (*) denotes a significant difference (P , 0.05) compared with other groups.
FIG. 6. AGT-2 stimulates ADAM17 mRNA abundance. Bovine granulosa cells were cultured as described in Figure 1 , and LH (100 ng/ml) or LH plus AGT-2 (10 À5 M) were added for the times shown. Messenger RNA abundance was measured by real-time PCR. Data represent the mean 6 SEM for three independent replicate cultures. An asterisk (*) denotes a significant effect of AGT-2 (P , 0.05) at each time point.
reflects serum withdrawal; serum has been demonstrated to stimulate PTGS2 mRNA in several cell types [43] [44] [45] . Nevertheless, PTGS2 mRNA levels are highly responsive to LH, as demonstrated by the dose-response experiment, suggesting that this cell model is useful for studying LHdependent periovulatory events in granulosa cells.
Direct evidence for the induction of ovulation by AGT-2 comes from studies with rabbits [17, 18] . Rabbits are induced ovulators; therefore, the mechanisms involved in ovulation may differ from those in other mammals. In the present study, AGT-2 consistently increased the abundance of mRNA encoding LH-stimulated genes that are directly involved in ovulation, including PLAU and PTGS2. AGT-2 alone (even at higher doses) had no effect, whereas LH alone at a high dose (400 ng/ml) was able to stimulate PTGS2 mRNA abundance to levels observed with the lower dose of LH plus AGT-2. These data suggest that AGT-2 facilitates or amplifies the action of LH on PTGS2 mRNA and protein expression and are consistent with studies in vivo in rodents and cattle demonstrating that AGT-2 receptor antagonists inhibit ovulation [19] [20] [21] . In the absence of AGT-2 signaling, the concentrations of LH observed during the preovulatory surge (,30 ng/ml) [46, 47] would be insufficient to provoke an adequate induction of PTGS2 activity and the downstream ovulatory cascade.
Luteinizing hormone induces PTGS2 expression in granulosa cells by stimulating the release of the EGF-like ligands, AREG and EREG, which then activate the EGF receptor and initiate the ovulatory cascade. No detailed in vivo time-course studies of AREG and EREG expression have been reported in cattle, but in the present culture system, LH increased EREG mRNA levels within 1 h and did not alter AREG mRNA levels until 6 h after challenge. This differs from the results of studies with mice in vivo, in which abundance of mRNA encoding each of these genes was increased within 1 h of hCG injection [14, 15, 48, 49] . If EREG expression is induced more rapidly than AREG in vivo in the cow, which remains to be confirmed, these results point to a clear species difference in the sequence of events leading to ovulation. The time from LH surge to ovulation is longer in cattle (28-30 h) than in rodents (12-14 h), and this may permit a temporal resolution between AREG and EREG induction in cattle. This temporal difference in the accumulation of EREG and AREG mRNA in bovine granulosa cells in vitro suggests that EREG may be the major catalyst for the subsequent AREG/EREG/PTGS2 autocrine and paracrine cascade within the follicle. This is supported by studies of knockout mice, in which Ereg-null mice exhibited a greater disruption of cumulus expansion and meiotic resumption than Areg-null mice [50] , and by the observation that Ereg-null mice had reduced ovarian Areg mRNA levels [48] .
It has been demonstrated that AGT-2 transactivates the EGFR by increasing heparin-binding EGF shedding in several cell types, including kidney [51, 52] and liver [53] cancer cells, cardiac microvascular endothelial cells [54] , and skin fibroblasts and keratinocytes [55] . Sheddase activity is also necessary for EGFR activation and stimulation of the ovulatory cascade [14] . One EGF-like ligand sheddase in granulosa cells is ADAM17. In porcine granulosa cells, FSH rapidly (within 1 h) increased ADAM17 mRNA levels, and this increase preceded changes in AREG mRNA levels [56] . In the present study, we show dramatic upregulation of ADAM17 mRNA by AGT-2 plus LH at 1 h posttreatment. ADAM17 mRNA abundance decreased to baseline by 6 h posttreatment, and this may explain why an increase in ADAM17 mRNA in granulosa cells was not observed in cattle 12 h after GnRH injection in vivo [57] . The metalloproteinase inhibitor Galardin, which inhibits ADAM activity, completely blocked the effects of LH plus AGT-2 on AREG, EREG, and PTGS2 mRNA, demonstrating that sheddase activity, not PTGS2, is a direct target of AGT-2.
The intracellular mechanism of AGT-2 action in the ovary is unknown, but we expected that MAPK3/1 phosphorylation would be a target pathway for two reasons. First, in nonreproductive tissues, AGT-2 activates AGTR1 and MAPK3/1 phosphorylation [27, 29, 31, 51, 53] . Second, the major pathways activated by LH or FSH for the induction of AREG and EREG gene expression in mice and pigs include MAPK3/1, MAPK14 (p38), and protein kinase A (PKA) [58, FIG. 7 . AGT-2 does not act through the AGTR1-MAPK3/1 pathway. Granulosa cells were cultured as described in Figure 1 . A) Effect of pretreatment with antagonists of AGTR1 (Los, Losartan), AGTR2 (PD, PD123,319), or vehicle control (C) on PTGS2 mRNA abundance 6 h after challenge with LH plus AGT-2. An LH-only control for the effect of AGT-2 was included. B) Effect of treatment on MAPK3/1 phosphorylation at 15 min posttreatment and EREG mRNA abundance (6 h posttreatment) in the same pools of cells. Data represent the mean 6 SEM for three independent replicate cultures. Bars without common letters are significantly different (P , 0.05).
1172 59]. However, studies with porcine cumulus cells demonstrated that inhibition of MAPK14 or PKA activity resulted in significant inhibition of MAPK3/1 phosphorylation [59] , suggesting that these pathways converge on MAPK3/1. Thus, we expected that AGT-2 would enhance MAPK3/1 phosphorylation in LH-stimulated cells, either directly or via MAPK14/ PKA, but the data show that this was not the case. This is likely owing to activation of AGTR2 and not AGTR1 by AGT-2 in the ovulatory process in vivo [17, 19, 21] and in vitro (present study). Thus, a marked difference was found between granulosa cells and other tissues studied in the receptor used by AGT-2 to exert its biological effects.
Collectively, the present results demonstrate that AGT-2 is an important cofactor for the induction of the ovulatory cascade and acts at the level of sheddase expression/activity to cause downstream increases in EREG mRNA accumulation. Because isolated granulosa cells do not appear to be able to produce AGT-2 from angiotensinogen [24] , the addition of AGT-2 to culture media may permit a full expression of the ovulatory cascade following low-dose LH treatment in vitro.
